scispace - formally typeset
M

Mary Anna Thrall

Researcher at Ross University School of Veterinary Medicine

Publications -  58
Citations -  2572

Mary Anna Thrall is an academic researcher from Ross University School of Veterinary Medicine. The author has contributed to research in topics: Ethylene glycol & CATS. The author has an hindex of 26, co-authored 57 publications receiving 2444 citations. Previous affiliations of Mary Anna Thrall include Colorado State University.

Papers
More filters
Book

Veterinary Hematology and Clinical Chemistry

TL;DR: This beautiful full--color reference is a comprehensive, practical guide to veterinary hematology and clinical chemistry, from basic principles and laboratory techniques to diagnostic evaluation.
Journal ArticleDOI

Critical role for glycosphingolipids in Niemann-Pick disease type C

TL;DR: Animals treated with N-butyldeoxynojirimycin (NB-DNJ), an inhibitor of glucosylceramide synthase, a pivotal enzyme in the early GSL synthetic pathway showed delayed onset of neurological dysfunction, increased average life span, and reduced ganglioside accumulation and accompanying neuropathological changes, suggesting that drugs inhibiting GSL synthesis could have a similar ameliorating effect on the human disorder.
Journal ArticleDOI

Proposed Criteria for Classification of Acute Myeloid Leukemia in Dogs and Cats

TL;DR: Blood and bone marrow smears from 49 dogs and cats, believed to have myeloproliferative disorders (MPD), were examined by a panel of 10 clinical pathologists to develop proposals for classification of acute myeloid leukemia (AML) in these species.
Journal ArticleDOI

GABAergic neuroaxonal dystrophy and other cytopathological alterations in feline Niemann-Pick disease type C

TL;DR: Clinical neurological signs in feline NPC occur in parallel with neuronal structural alterations and suggest that GABAergic neuroaxonal dystrophy is a contributor to brain dysfunction in this disease.
Journal ArticleDOI

Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation

TL;DR: Allogeneic bone marrow transplantation (BMT) offers promise for cure of certain inborn errors of metabolism and BMT-induced correction of this hereditary enzyme deficiency in cats and children affected with MPS VI.